nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—CYP3A4—bone cancer	0.498	1	CbGaD
Doxycycline—SLC22A11—Methotrexate—bone cancer	0.0822	0.477	CbGbCtD
Doxycycline—SLC22A8—Methotrexate—bone cancer	0.0478	0.277	CbGbCtD
Doxycycline—SLC22A6—Methotrexate—bone cancer	0.0333	0.193	CbGbCtD
Doxycycline—MMP13—knee—bone cancer	0.0245	0.137	CbGeAlD
Doxycycline—MMP1—knee—bone cancer	0.0172	0.0963	CbGeAlD
Doxycycline—MMP13—periosteum—bone cancer	0.0168	0.0943	CbGeAlD
Doxycycline—MMP13—leg—bone cancer	0.0134	0.0752	CbGeAlD
Doxycycline—MMP13—forelimb—bone cancer	0.0133	0.0746	CbGeAlD
Doxycycline—MMP13—hindlimb—bone cancer	0.012	0.0671	CbGeAlD
Doxycycline—MMP13—cartilage tissue—bone cancer	0.0118	0.0661	CbGeAlD
Doxycycline—MMP8—cartilage tissue—bone cancer	0.0106	0.0596	CbGeAlD
Doxycycline—MMP13—appendage—bone cancer	0.0103	0.0576	CbGeAlD
Doxycycline—MMP1—leg—bone cancer	0.00943	0.0528	CbGeAlD
Doxycycline—CYP3A4—Doxorubicin—bone cancer	0.00917	0.0532	CbGbCtD
Doxycycline—MMP1—hindlimb—bone cancer	0.00843	0.0472	CbGeAlD
Doxycycline—MMP1—cartilage tissue—bone cancer	0.00829	0.0465	CbGeAlD
Doxycycline—MMP1—appendage—bone cancer	0.00723	0.0405	CbGeAlD
Doxycycline—MMP13—Collagen formation—PLOD2—bone cancer	0.00475	0.0324	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—PLOD2—bone cancer	0.00459	0.0313	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—LOX—bone cancer	0.00344	0.0235	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—LOX—bone cancer	0.00332	0.0227	CbGpPWpGaD
Doxycycline—MMP13—connective tissue—bone cancer	0.00293	0.0164	CbGeAlD
Doxycycline—MMP8—connective tissue—bone cancer	0.00265	0.0148	CbGeAlD
Doxycycline—MMP8—Extracellular matrix organization—PLOD2—bone cancer	0.0026	0.0178	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP2—bone cancer	0.00235	0.0161	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—LOX—bone cancer	0.00235	0.016	CbGpPWpGaD
Doxycycline—MMP7—connective tissue—bone cancer	0.00234	0.0131	CbGeAlD
Doxycycline—MMP7—Collagen formation—LOX—bone cancer	0.00226	0.0155	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP2—bone cancer	0.00224	0.0153	CbGpPWpGaD
Doxycycline—MMP1—connective tissue—bone cancer	0.00206	0.0116	CbGeAlD
Doxycycline—MMP13—tendon—bone cancer	0.00202	0.0113	CbGeAlD
Doxycycline—MMP8—Collagen degradation—MMP2—bone cancer	0.00195	0.0133	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—ATF1—bone cancer	0.00194	0.0132	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—PLOD2—bone cancer	0.0019	0.013	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—bone cancer	0.00188	0.0128	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—bone cancer	0.00188	0.452	CrCbGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CHEK2—bone cancer	0.00186	0.0127	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—PLOD2—bone cancer	0.00183	0.0125	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—IGF1R—bone cancer	0.00177	0.0121	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—bone cancer	0.00177	0.0121	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—MMP2—bone cancer	0.00176	0.012	CbGpPWpGaD
Doxycycline—MMP8—bone marrow—bone cancer	0.00176	0.00987	CbGeAlD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP2—bone cancer	0.00172	0.0117	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—bone cancer	0.00169	0.0116	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—bone cancer	0.00168	0.0115	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—PLAU—bone cancer	0.00166	0.0114	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP2—bone cancer	0.00166	0.0113	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MET—bone cancer	0.00165	0.0112	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP2—bone cancer	0.00163	0.0111	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP2—bone cancer	0.00158	0.0108	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—GNA11—bone cancer	0.00156	0.0107	CbGpPWpGaD
Doxycycline—Rolitetracycline—CYP3A4—bone cancer	0.00156	0.376	CrCbGaD
Doxycycline—MMP1—Bladder Cancer—CDK4—bone cancer	0.00155	0.0106	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—PLOD2—bone cancer	0.00147	0.01	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—bone cancer	0.00146	0.01	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—IGF1R—bone cancer	0.00146	0.00995	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—PLAU—bone cancer	0.00142	0.00971	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP2—bone cancer	0.00142	0.0097	CbGpPWpGaD
Doxycycline—MMP1—tendon—bone cancer	0.00142	0.00794	CbGeAlD
Doxycycline—MMP7—Collagen degradation—MMP2—bone cancer	0.00137	0.00937	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—BRAF—bone cancer	0.00137	0.00935	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—MET—bone cancer	0.00137	0.00932	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—RB1—bone cancer	0.00135	0.00919	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP2—bone cancer	0.00133	0.00905	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MET—bone cancer	0.00132	0.00898	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—bone cancer	0.00129	0.00881	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—LOX—bone cancer	0.00129	0.00878	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP2—bone cancer	0.00126	0.00859	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—bone cancer	0.00125	0.00851	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—bone cancer	0.00123	0.00837	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—PLAU—bone cancer	0.00119	0.00811	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—bone cancer	0.00118	0.00808	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDK4—bone cancer	0.00117	0.00799	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MDM2—bone cancer	0.00115	0.00784	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—bone cancer	0.00112	0.00765	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP2—bone cancer	0.0011	0.00749	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—bone cancer	0.00107	0.00729	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—bone cancer	0.00103	0.00704	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—bone cancer	0.00103	0.00704	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—RB1—bone cancer	0.00102	0.00694	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—bone cancer	0.000997	0.0068	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—bone cancer	0.000986	0.00673	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—bone cancer	0.000986	0.00673	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SPARC—bone cancer	0.000964	0.00658	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—bone cancer	0.000946	0.00646	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LOX—bone cancer	0.000938	0.0064	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—bone cancer	0.000914	0.00624	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LOX—bone cancer	0.000906	0.00619	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—bone cancer	0.000883	0.00602	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MDM2—bone cancer	0.000867	0.00592	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—JUN—bone cancer	0.000866	0.00591	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PLAU—bone cancer	0.000854	0.00583	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—bone cancer	0.000843	0.00575	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—bone cancer	0.000831	0.00567	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—bone cancer	0.000825	0.00563	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—bone cancer	0.000825	0.00563	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MOGS—bone cancer	0.000806	0.0055	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—bone cancer	0.000803	0.00548	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—bone cancer	0.000797	0.00544	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—PLAU—bone cancer	0.00079	0.00539	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—bone cancer	0.000784	0.00535	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000769	0.00525	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—bone cancer	0.000741	0.00506	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LOX—bone cancer	0.000724	0.00494	CbGpPWpGaD
Doxycycline—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000723	0.00494	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000722	0.00493	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—bone cancer	0.000719	0.00491	CbGpPWpGaD
Doxycycline—Tetracycline—CYP3A4—bone cancer	0.000717	0.173	CrCbGaD
Doxycycline—MMP13—AGE/RAGE pathway—JUN—bone cancer	0.000706	0.00482	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—bone cancer	0.000704	0.00481	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SPARC—bone cancer	0.000703	0.0048	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—bone cancer	0.000695	0.00474	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000694	0.00474	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—bone cancer	0.000692	0.00472	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—bone cancer	0.000687	0.00469	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—JUN—bone cancer	0.000682	0.00465	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SPARC—bone cancer	0.000679	0.00463	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFBR2—bone cancer	0.00067	0.00458	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—bone cancer	0.000663	0.00453	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—bone cancer	0.000659	0.0045	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000602	0.00411	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000588	0.00402	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—bone cancer	0.000566	0.00387	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—JUN—bone cancer	0.000566	0.00386	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—bone cancer	0.000556	0.00379	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—bone cancer	0.000555	0.00379	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—bone cancer	0.000547	0.00373	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SPARC—bone cancer	0.000543	0.00371	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—bone cancer	0.000541	0.00369	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—bone cancer	0.000536	0.00366	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000527	0.0036	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—bone cancer	0.000522	0.00356	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—JUN—bone cancer	0.00052	0.00355	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—bone cancer	0.000506	0.00345	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—bone cancer	0.000498	0.0034	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MET—bone cancer	0.000486	0.00332	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—JUN—bone cancer	0.000481	0.00329	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—bone cancer	0.000472	0.00322	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000458	0.00313	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—TUBB4B—bone cancer	0.000442	0.00302	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000436	0.00298	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—bone cancer	0.000434	0.00297	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—bone cancer	0.000418	0.00285	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000415	0.00284	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—bone cancer	0.000413	0.00282	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000386	0.00264	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—TUBB2A—bone cancer	0.000381	0.0026	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000379	0.00259	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—bone cancer	0.000364	0.00249	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—bone cancer	0.000343	0.00234	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000331	0.00226	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.000323	0.00221	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SPARC—bone cancer	0.000323	0.0022	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—bone cancer	0.000318	0.00217	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—JUN—bone cancer	0.000313	0.00214	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—bone cancer	0.000311	0.00212	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—bone cancer	0.000302	0.00206	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—bone cancer	0.000301	0.00206	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—GNA11—bone cancer	0.000295	0.00201	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—bone cancer	0.000291	0.00199	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000285	0.00194	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000281	0.00192	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IL3—bone cancer	0.000267	0.00183	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—EIF2S1—bone cancer	0.000266	0.00182	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000246	0.00168	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—bone cancer	0.000233	0.00159	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—bone cancer	0.000227	0.00155	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000221	0.00151	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—bone cancer	0.000219	0.00149	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000217	0.00148	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—bone cancer	0.000207	0.00141	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000187	0.00128	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000186	0.00127	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000181	0.00124	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAU—bone cancer	0.000175	0.0012	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—bone cancer	0.000175	0.00119	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000156	0.00107	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—bone cancer	0.000109	0.000743	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	8.76e-05	0.000598	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—bone cancer	7.05e-05	0.000481	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTP1—bone cancer	5.67e-05	0.000387	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	5.6e-05	0.000382	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NDUFA12—bone cancer	3.98e-05	0.000271	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NT5C3A—bone cancer	3.29e-05	0.000225	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ENO2—bone cancer	1.44e-05	9.85e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—DHFR—bone cancer	1.34e-05	9.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GNA11—bone cancer	1.25e-05	8.54e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTP1—bone cancer	9.7e-06	6.62e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—bone cancer	5.03e-06	3.43e-05	CbGpPWpGaD
